leisure time -WSS

leisure time

author：focus 2025-09-27 12:22:29 - browse：8974

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Wegovy trial has doctors encouraged over new possibilities

WSS

Friends ask where James Watson's attitudes about race came from

What to know about Virgin Galactic's 1st mission taking paying customers to space

The strange history of BMI, the body mass index

Drastic changes should bring profitability, startup health insurers say

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

NIH trials fail to test meaningful long Covid therapies, experts say

knowledge

leisure time

focus

The cancer drug shortage isn’t new — and neither are the solutions

The simple reason for the increase in autism diagnosis

Medical leaders decry Supreme Court decision on affirmative action

What to know about Virgin Galactic's 1st mission taking paying customers to space

How to save PrEP access — and even expand it

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Bright Health sells Medicare Advantage business to Molina

Maui's cultural, historic landmarks damaged in the devastating wildfires

At least 13 dead in Texas as scorching temps continue

Wegovy’s successful heart trial raises vital question about weight loss

explore

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

For Cytokinetics, FDA rejection of heart drug would help, not hinder

The best solution to the drug shortages problem

Here's how to stay safe from wildfire smoke amid reduced air quality

A biotech analyst on neuroscience, placebo effect, not over

Maui's cultural, historic landmarks damaged in the devastating wildfires

hotspot

focus

explore

explore